4.6 Review

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment

Journal

CANCER TREATMENT REVIEWS
Volume 68, Issue -, Pages 69-79

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2018.05.015

Keywords

Immune checkpoint inhibitors; Brain metastases; Central nervous system; Non-small cell lung cancer; Radiation therapy

Categories

Funding

  1. DUERTECC/EURONCO grant (Diplome Universitaire Europeen de Recherche Translationelle Et Clinique en Cancerologie) 2017-2018

Ask authors/readers for more resources

Brain metastases (BM) are diagnosed frequently in non-small cell lung cancer (NSCLC) patients. Despite the high incidence of BM (up to 40% in unselected patients), patients with untreated and/or unstable BM were excluded from pivotal immune checkpoint inhibitors (ICI) NSCLC trials. Percentage of patients with stable and treated BM in these trials ranged from 9.1 to 14.7% and ICI benefit over chemotherapy was not always demonstrated. Only small trials have been completed that demonstrated ICI efficacy in locally untreated, selected BM patients. With 33%, cranial objective response rate (ORR) was comparable to extracranial ORR and responses were often durable. With the promising survival benefits of ICI, in daily practice also unstable and/or untreated BM patients will often receive treatment with ICI and extrapolating clinical trial data to these patients can be challenging. In this review, we will summarize the preclinical rationale and potential concerns for the use of ICI in BM patients. Furthermore, we will summarize BM subgroup data from the pivotal NSCLC trials, retrospective series, the NSCLC BM specific ICI trials and the use of cranial radiation and Ia. Last, we provide an overview of response measurement criteria and future directions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available